Your browser doesn't support javascript.
loading
Shared genetic background between children and adults with attention deficit/hyperactivity disorder.
Rovira, Paula; Demontis, Ditte; Sánchez-Mora, Cristina; Zayats, Tetyana; Klein, Marieke; Mota, Nina Roth; Weber, Heike; Garcia-Martínez, Iris; Pagerols, Mireia; Vilar-Ribó, Laura; Arribas, Lorena; Richarte, Vanesa; Corrales, Montserrat; Fadeuilhe, Christian; Bosch, Rosa; Martin, Gemma Español; Almos, Peter; Doyle, Alysa E; Grevet, Eugenio Horacio; Grimm, Oliver; Halmøy, Anne; Hoogman, Martine; Hutz, Mara; Jacob, Christian P; Kittel-Schneider, Sarah; Knappskog, Per M; Lundervold, Astri J; Rivero, Olga; Rovaris, Diego Luiz; Salatino-Oliveira, Angelica; da Silva, Bruna Santos; Svirin, Evgeniy; Sprooten, Emma; Strekalova, Tatyana; Arias-Vasquez, Alejandro; Sonuga-Barke, Edmund J S; Asherson, Philip; Bau, Claiton Henrique Dotto; Buitelaar, Jan K; Cormand, Bru; Faraone, Stephen V; Haavik, Jan; Johansson, Stefan E; Kuntsi, Jonna; Larsson, Henrik; Lesch, Klaus-Peter; Reif, Andreas; Rohde, Luis Augusto; Casas, Miquel; Børglum, Anders D.
Afiliación
  • Rovira P; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Demontis D; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • Sánchez-Mora C; Department of Biomedicine (Human Genetics), and Centre for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark.
  • Zayats T; The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
  • Klein M; Center for Genomics and Personalized Medicine, Aarhus, Denmark.
  • Mota NR; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Weber H; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • Garcia-Martínez I; Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
  • Pagerols M; Department of Genetics, Microbiology, and Statistics, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain.
  • Vilar-Ribó L; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Arribas L; Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA.
  • Richarte V; Stanley Center for Psychiatric Research, Broad Institute of MIT, and Harvard, Cambridge, MA, USA.
  • Corrales M; Department of Human Genetics, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Fadeuilhe C; University Medical Center Utrecht, UMC Utrecht Brain Center, Department of Psychiatry, Utrecht, The Netherlands.
  • Bosch R; Department of Human Genetics, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Martin GE; ADHD Outpatient Program, Adult Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • Almos P; Department of Psychiatry, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Doyle AE; Department of Psychiatry, Psychosomatics, and Psychotherapy, University of Würzburg, Würzburg, Germany.
  • Grevet EH; Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Grimm O; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Halmøy A; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • Hoogman M; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Hutz M; Grup de Medicina Transfusional, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain.
  • Jacob CP; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Kittel-Schneider S; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • Knappskog PM; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Lundervold AJ; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • Rivero O; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Rovaris DL; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • Salatino-Oliveira A; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • da Silva BS; Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
  • Svirin E; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Sprooten E; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • Strekalova T; Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
  • Arias-Vasquez A; Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
  • Sonuga-Barke EJS; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Asherson P; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • Bau CHD; Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
  • Buitelaar JK; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Cormand B; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
  • Faraone SV; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Haavik J; Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.
  • Johansson SE; Division of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany.
  • Kuntsi J; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Larsson H; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Lesch KP; ADHD Outpatient Program, Adult Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • Reif A; Department of Psychiatry, Faculty of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Rohde LA; Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Casas M; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Børglum AD; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Neuropsychopharmacology ; 45(10): 1617-1626, 2020 09.
Article en En | MEDLINE | ID: mdl-32279069
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Child / Humans Idioma: En Revista: Neuropsychopharmacology Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Child / Humans Idioma: En Revista: Neuropsychopharmacology Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: España